CureVac’s “RNA Printer”
May 17, 2022 | Terry Sharrer
“CureVac, a German biotech, formed a new subsidiary centered on the company’s RNA Printer technology that integrates and automates the manufacturing process for RNA vaccines and therapeutics. CureVac RNA Printer GmbH, a wholly owned subsidiary of CureVac, launched this week to provide services for clients and to further develop the tech as an end-to-end solution. The RNA printer has moved from the prototype stage to a fully functional facility located at CureVac’s headquarters in Tübingen, Germany . . . .” MORE
Image Credit: FiercePharma.com